New Developments in the Genetics of Bipolar Disorder

Current Psychiatry Reports

Volumn 16, Issue 11, 2014, Pages

  Shinozaki, Gen ^a   Potash, James B ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Association, Sequencing; Bipolar disorder; Genetics; Methylation; Subphenotype

Indexed keywords

DNA; LITHIUM SALT;

ANK3 GENE; ANTERIOR CINGULATE; BEHAVIOR GENETICS; BIPOLAR DISORDER; BRAIN DYSFUNCTION; CACNA1C GENE; COPY NUMBER VARIATION; DNA SEQUENCE; EPIGENETICS; EPISODIC MEMORY; GENE; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; MEMORY CONSOLIDATION; NEXT GENERATION SEQUENCING; NONHUMAN; ODZ4 GENE; PATHOGENESIS; PHARMACOGENETICS; PHENOTYPE; PSYCHOSIS; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SUICIDE ATTEMPT; SYNE1 GENE; TRANK1 GENE; GENETICS;

BIPOLAR DISORDER; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 84920287742     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-014-0493-5     Document Type: Review

References (72)

1. Potash JB, DePaulo Jr JR. Searching high and low: a review of the genetics of bipolar disorder. Bipolar Disord. 2000;2(1):8–26.
2. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78.
3. Baum AE et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry. 2008;13(2):197–207.
4. Ferreira MA et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008;40(9):1056–8.
5. Sklar P et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13(6):558–69.
6. Lee MT et al. Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry. 2011;16(5):548–56.
7. Hattori E et al. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(8):1110–7.
8. Djurovic S et al. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J Affect Disord. 2010;126(1–2):312–6.
9. Cichon S et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet. 2011;88(3):372–81.
10. Yosifova A et al. Genome-wide association study on bipolar disorder in the Bulgarian population. Genes Brain Behav. 2011;10(7):789–97.
11. Xu W et al. Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med Genet. 2014;15:2.
12. Smith EN et al. Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes. PLoS Genet. 2011;7(6):e1002134.
13. Smith EN et al. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry. 2009;14(8):755–63.
14. Psychiatric Genomics Consortium-Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011;43(10):977–83.
15. Muhleisen TW et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun. 2014;5:3339. The largest BPD GWAS to date with >24,000 patients and controls.
16. Chen DT et al. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry. 2013;18(2):195–205. This study of >17,000 subjects implicated TRANK1 in BPD.
17. Nurnberger Jr JI et al. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry. 2014;71(6):657–64.
18. Heinrich A et al. The risk variant in ODZ4 for bipolar disorder impacts on amygdala activation during reward processing. Bipolar Disord. 2013;15(4):440–5.
19. Soeiro-de-Souza MG et al. The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls. J Affect Disord. 2012;141(1):94–101.
20. Soeiro-de-Souza MG et al. The CACNA1C risk allele selectively impacts on executive function in bipolar type I disorder. Acta Psychiatr Scand. 2013;128(5):362–9.
21. Tesli M et al. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS ONE. 2013;8(2):e56970.
22. Roussos P et al. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord. 2011;13(3):250–9.
23. Ruberto G et al. The cognitive impact of the ANK3 risk variant for bipolar disorder: initial evidence of selectivity to signal detection during sustained attention. PLoS ONE. 2011;6(1):e16671.
24. Wessa M et al. The CACNA1C risk variant for bipolar disorder influences limbic activity. Mol Psychiatry. 2010;15(12):1126–7.
25. Radua J et al. The impact of CACNA1C allelic variation on effective connectivity during emotional processing in bipolar disorder. Mol Psychiatry. 2013;18(5):526–7.
26. Dima D et al. Independent modulation of engagement and connectivity of the facial network during affect processing by CACNA1C and ANK3 risk genes for bipolar disorder. JAMA Psychiatry. 2013;70(12):1303–11.
27. Dietsche B et al. The impact of a CACNA1C gene polymorphism on learning and hippocampal formation in healthy individuals: a diffusion tensor imaging study. Neuroimage. 2014;89:256–61.
28. Bigos KL et al. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry. 2010;67(9):939–45.
29. Erk S et al. Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiatry. 2010;67(8):803–11.
30. Erk, S., et al., Hippocampal and frontolimbic function as intermediate phenotype for psychosis: evidence from healthy relatives and a common risk variant in CACNA1C. Biol Psychiatry, 2013.
31. Erk S et al. Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects. Neuroimage. 2014;94:147–54.
32. Schulze TG et al. What is familial about familial bipolar disorder? Resemblance among relatives across a broad spectrum of phenotypic characteristics. Arch Gen Psychiatry. 2006;63(12):1368–76.
33. Potash JB et al. The bipolar disorder phenome database: a resource for genetic studies. Am J Psychiatry. 2007;164(8):1229–37.
34. Willour VL et al. A genome-wide association study of attempted suicide. Mol Psychiatry. 2012;17(4):433–44.
35. Goes FS et al. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry. 2007;164(2):236–47.
36. O'Mahony E et al. Sibling pairs with affective disorders: resemblance of demographic and clinical features. Psychol Med. 2002;32(1):55–61.
37. Potash JB et al. The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. Am J Psychiatry. 2001;158(8):1258–64.
38. Belmonte Mahon P et al. Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2011;156B(3):370–8.
39. Hamshere ML et al. Polygenic dissection of the bipolar phenotype. Br J Psychiatry. 2011;198(4):284–8.
40. Goes FS et al. Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl Psychiatry. 2012;2:e180.
41. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984–94.
42. Cross-Disorder Group of the Psychiatric Genomics Consortium and Consortium for Genetic Risk Outcome of Psychosis. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381(9875):1371–9.
43. Leussis MP et al. The ANK3 bipolar disorder gene regulates psychiatric-related behaviors that are modulated by lithium and stress. Biol Psychiatry. 2013;73(7):683–90. Interesting example of examination of the function of a GWAS-implicated BPD gene in an animal model.
44. Durak O et al. Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of beta-catenin. Mol Psychiatry. 2014. doi:10.1038/mp.2014.42.
45. Zhang D et al. Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry. 2009;14(4):376–80.
46. Grozeva D et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry. 2010;67(4):318–27.
47. Malhotra D et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron. 2011;72(6):951–63.
48. Bergen SE et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry. 2012;17(9):880–6.
49. Georgieva, L., et al., De novo CNVs in bipolar affective disorder and schizophrenia. Hum Mol Genet. 2014.
50. Chen YC et al. A hybrid likelihood model for sequence-based disease association studies. PLoS Genet. 2013;9(1):e1003224.
51. Cruceanu C et al. Family-based exome-sequencing approach identifies rare susceptibility variants for lithium-responsive bipolar disorder. Genome. 2013;56(10):634–40.
52. Georgi B et al. Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate. PLoS Genet. 2014;10(3):e1004229.
53. Fiorentino A et al. Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data. Bipolar Disord. 2014. doi:10.1111/bdi.12203.
54. Akula N et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry. 2014. doi:10.1038/mp.2013.170.
55. Xiao Y et al. The DNA methylome and transcriptome of different brain regions in schizophrenia and bipolar disorder. PLoS ONE. 2014;9(4):e95875.
56. Lin PI et al. Clinical correlates and familial aggregation of age at onset in bipolar disorder. Am J Psychiatry. 2006;163(2):240–6.
57. Sugawara H et al. Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell lines. Epigenetics. 2011;6(4):508–15.
58. Kaminsky Z et al. A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. Mol Psychiatry. 2012;17(7):728–40.
59. Carrard A et al. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J Affect Disord. 2011;132(3):450–3.
60. Nohesara S et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res. 2011;45(11):1432–8.
61. Ghadirivasfi M et al. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2011;156B(5):536–45.
62. Abdolmaleky HM et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr Res. 2011;129(2–3):183–90.
63. Abdolmaleky HM et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 2006;15(21):3132–45.
64. Dempster EL et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011;20(24):4786–96.
65. Mill J et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008;82(3):696–711.
66. Nishioka M et al. Neuronal cell-type specific DNA methylation patterns of the Cacna1c gene. Int J Dev Neurosci. 2013;31(2):89–95.
67. Grof P et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry. 2002;63(10):942–7.
68. Perlis RH et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry. 2009;166(6):718–25.
69. Chen CH et al. Variant GADL1 and response to lithium therapy in bipolar I disorder. N Engl J Med. 2014;370(2):119–28. High profile paper suggests that a single SNP determines lithium response in East Asians.
70. Ikeda M, Kondo K, Iwata N. Variant GADL1 and response to lithium in bipolar I disorder. N Engl J Med. 2014;370(19):1856–7. A failure to replicate the high profile Chen et al. result.
71. Consortium on Lithium Genetics., et al., Variant GADL1 and response to lithium in bipolar I disorder. N Engl J Med, 2014. 370(19):1857–9. A failure to replicate the high profile Chen et al. result.
72. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–7.